Table 1

Participant characteristics*

VariablePatients with RA (n=223)Controls (n=31 684)P value
Women, n139 (62%)17 615 (57%)0.044
Age, years65 (58, 72)54 (42, 64)<0.001
Body mass index, kg/m227.4 (24.5, 30.5)26.6 (24.1, 29.5)0.015
Total cholesterol, mmol/L5.6 (4.7, 6.3)5.4 (4.7, 6.2)0.30
HDL cholesterol, mmol/L1.3 (1.1, 1.6)1.3 (1.1, 1.6)0.11
Creatinine, μmol/L84 (74, 94)82 (73, 92)0.15
Diabetes, n18 (8%)1335 (4%)0.004
Hypertension, n138 (62%)12 757 (40%)<0.001
Smoking<0.001
 Never smoker79 (35%)15 638 (49%)
 Previous smoker97 (44%)10 033 (32%)
 Present smoker47 (21%)6013 (19%)
C-reactive protein, mg/L2.4 (1.2, 6.5)1.2 (0.6, 2.6)<0.001
C-reactive protein ≥3.0 mg/L, n98 (44%)6867 (22%)<0.001
C-reactive protein ≥5.0 mg/L, n66 (30%)3767 (12%)<0.001
eCRF, mL×min−1×kg−126.1 (20.1, 30.8)35.1 (35.0, 35.2)<0.001
Mortality, n543124<0.001
Mortality, %†24.1 (18.1, 31.6)9.9 (9.5, 10.2)
Age at RA diagnosis, years55 (46, 63)NA
Years with RA at HUNT35 (9, 16)NA
Seropositive‡157 (70%)NA
  • *Data are given as number (%) or median (25th,75th percentile). Patients with RA and controls were compared using the Χ2 test or Mann-Whitney U test.

  • †95% CIs in parentheses, calculated using the binomial distribution.

  • ‡Seropositive: positive for IgM rheumatoid factor and/or anti-citrullinated protein antibodies.

  • eCRF, estimated cardiorespiratory fitness; HDL, high-density lipoprotein; HUNT3, third survey of the Trøndelag Health Study; NA, not applicable; RA, rheumatoid arthritis.